Notice for sebetralstat (JACE Pharma Pty Ltd)
Active ingredients
sebetralstat
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
tablet
Indication
For the treatment of hereditary angioedema
Therapeutic area
Immunology